| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Hims & Hers Health, Inc. (HIMS) has 15 insiders with recent SEC Form 4 filings, including 1 buy and 26 sells. HIMS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 460.9K | $15.07M | - | |
| COO | 432.1K | $14.13M | -14,027 | |
| Other | 176.4K | $5.77M | - | |
| CFO | 160.9K | $5.26M | - | |
| Other | 141.1K | $4.61M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2024 | Baird Melissa | Chief Operating Officer | Sale+OE | 105,756 | $20.54 | $2,171,786.89 | -3.1% | -33.3% | +142.6% | |
| Jun 4, 2024 | Dudum Andrew48 | Chief Executive Officer | Sale+OE | 333,332 | $19.88 | $6,626,197.80 | -12.0% | -30.4% | +157.4% | |
| Jun 3, 2024 | Chi Michael | Chief Commercial Officer | Sale+OE | 521,380 | $19.79 | $10,319,439.38 | -32.0% | -29.2% | +167.1% | |
| May 30, 2024 | Boughton Soleil | Chief Legal Officer | Sale+OE | 129,667 | $20.55 | $2,665,244.15 | -28.3% | -28.1% | +177.7% | |
| May 28, 2024 | Boughton Soleil | Chief Legal Officer | Sell | 2,502 | $17.33 | $43,359.66 | -1.6% | -16.0% | +179.3% | |
| May 21, 2024 | Payne Christopher D77 | Director | Buy | 110,000 | $17.74 | $1,951,763.00 | New | -5.7% | +230.3% | |
| May 21, 2024 | Okupe Oluyemi55 | Chief Financial Officer | Sale+OE | 45,031 | $18.20 | $819,732.28 | -6.7% | -5.7% | +230.3% | |
| May 20, 2024 | Boughton Soleil | Chief Legal Officer | Sale+OE | 4,915 | $20.01 | $98,372.74 | -3.0% | -11.0% | +229.1% | |
| May 17, 2024 | Becklund Irene | Pao | Sale+OE | 943 | $14.50 | $13,673.50 | -100% | +7.8% | +343.7% | |
| May 13, 2024 | Pendarvis Christiane | Director | Sell | 4,000 | $12.33 | $49,320.00 | -26.3% | +23.9% | +396.5% |